Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2005 1
2007 1
2008 2
2009 5
2010 3
2011 2
2012 4
2013 3
2014 2
2015 2
2016 1
2018 5
2019 2
2020 3
2021 2
2022 3
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Small molecule activators of the p53 response.
Ladds MJGW, Laín S. Ladds MJGW, et al. Among authors: lain s. J Mol Cell Biol. 2019 Mar 1;11(3):245-254. doi: 10.1093/jmcb/mjz006. J Mol Cell Biol. 2019. PMID: 30689917 Free PMC article. Review.
p53-based cancer therapy.
Lane DP, Cheok CF, Lain S. Lane DP, et al. Among authors: lain s. Cold Spring Harb Perspect Biol. 2010 Sep;2(9):a001222. doi: 10.1101/cshperspect.a001222. Epub 2010 May 12. Cold Spring Harb Perspect Biol. 2010. PMID: 20463003 Free PMC article. Review.
Sirtuins and p53.
van Leeuwen I, Lain S. van Leeuwen I, et al. Among authors: lain s. Adv Cancer Res. 2009;102:171-95. doi: 10.1016/S0065-230X(09)02005-3. Adv Cancer Res. 2009. PMID: 19595309 Review.
Therapeutic exploitation of the p53 pathway.
Lane DP, Lain S. Lane DP, et al. Among authors: lain s. Trends Mol Med. 2002;8(4 Suppl):S38-42. doi: 10.1016/s1471-4914(02)02309-2. Trends Mol Med. 2002. PMID: 11927286 Review.
Awakening guardian angels: drugging the p53 pathway.
Brown CJ, Lain S, Verma CS, Fersht AR, Lane DP. Brown CJ, et al. Among authors: lain s. Nat Rev Cancer. 2009 Dec;9(12):862-73. doi: 10.1038/nrc2763. Nat Rev Cancer. 2009. PMID: 19935675 Review.
Publisher Correction: A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage.
Ladds MJGW, van Leeuwen IMM, Drummond CJ, Chu S, Healy AR, Popova G, Fernández AP, Mollick T, Darekar S, Sedimbi SK, Nekulova M, Sachweh MCC, Campbell J, Higgins M, Tuck C, Popa M, Safont MM, Gelebart P, Fandalyuk Z, Thompson AM, Svensson R, Gustavsson AL, Johansson L, Färnegårdh K, Yngve U, Saleh A, Haraldsson M, D'Hollander ACA, Franco M, Zhao Y, Håkansson M, Walse B, Larsson K, Peat EM, Pelechano V, Lunec J, Vojtesek B, Carmena M, Earnshaw WC, McCarthy AR, Westwood NJ, Arsenian-Henriksson M, Lane DP, Bhatia R, McCormack E, Laín S. Ladds MJGW, et al. Among authors: lain s. Nat Commun. 2023 Aug 18;14(1):5019. doi: 10.1038/s41467-023-40764-2. Nat Commun. 2023. PMID: 37596290 Free PMC article. No abstract available.
Drug discovery in the p53 field.
Lain S. Lain S. Semin Cancer Biol. 2010 Feb;20(1):1-2. doi: 10.1016/j.semcancer.2010.03.003. Epub 2010 Mar 30. Semin Cancer Biol. 2010. PMID: 20359536 No abstract available.
Constitutive activation of WASp in X-linked neutropenia renders neutrophils hyperactive.
Keszei M, Record J, Kritikou JS, Wurzer H, Geyer C, Thiemann M, Drescher P, Brauner H, Köcher L, James J, He M, Baptista MA, Dahlberg CI, Biswas A, Lain S, Lane DP, Song W, Pütsep K, Vandenberghe P, Snapper SB, Westerberg LS. Keszei M, et al. Among authors: lain s. J Clin Invest. 2021 Dec 1;131(23):e156513. doi: 10.1172/JCI156513. J Clin Invest. 2021. PMID: 34850746 Free PMC article. No abstract available.
Mechanism-specific signatures for small-molecule p53 activators.
van Leeuwen IM, Higgins M, Campbell J, Brown CJ, McCarthy AR, Pirrie L, Westwood NJ, Laín S. van Leeuwen IM, et al. Among authors: lain s. Cell Cycle. 2011 May 15;10(10):1590-8. doi: 10.4161/cc.10.10.15519. Epub 2011 May 15. Cell Cycle. 2011. PMID: 21490429
47 results